Most Recent
International currency exchange company Travelex has won its opposition to three trade marks by blockchain travel company Travelx.
AI tech company Paige can't patent a tool to provide quality control for analysis of pathology images, with IP Australia finding the invention is merely an “administrative scheme” to automate the role of human pathologists.
The scope of protection for geographical indications will be at issue in India's appeal of a decision that barred it from registering a trade mark for basmati rice.
Coles has defeated a trade mark challenge to its Perform brand of sports nutrition products by a sports equipment company.
Aristocrat has asked the High Court to rule once and for all on whether its popular Lightning Link game is patentable, after a differently comprised court was evenly split on the question.
IP Australia has rejected AFT Pharmaceuticals’ bid to patent a combination cold and flu medication, finding the invention was little more than putting three different medications “in a box”.
The Pakistani government's opposition to India's attempt to register a composite 'Basmati' trade mark will go on despite filing delays, with a delegate finding it was in the public interest to allow the opposition.
The patent office has rejected Visa's application to patent a token system for securing customer data, finding the process did not address a technical problem or provide a technical solution.
A GlaxoSmithKline unit has defeated Nova Pharmaceuticals' bid to trade mark 'Novadart' for a generic version of the British company's market-leading drug prostate drug 'Avodart', with a delegate finding the mark would cause consumer confusion.
US-based Dana-Farber Cancer Institute has succeeded in patenting a patient-specific method for developing cancer vaccines using genome sequencing.